119 related articles for article (PubMed ID: 8337131)
1. Residual immunological risks associated with red blood cell transfusion.
Rouger P; Le Pennec PY
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
[No Abstract] [Full Text] [Related]
2. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
[No Abstract] [Full Text] [Related]
3. [Transfusion: risks and future prospects].
Molaro GL
G Clin Med; 1990 Oct; 71(10):547-59. PubMed ID: 2289650
[No Abstract] [Full Text] [Related]
4. Risks of blood transfusion and their prevention.
Sandler SG; Yu H; Rassai N
Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
[TBL] [Abstract][Full Text] [Related]
5. Red cell transfusion and the immune system.
Hart S; Cserti-Gazdewich CM; McCluskey SA
Anaesthesia; 2015 Jan; 70 Suppl 1():38-45, e13-6. PubMed ID: 25440393
[TBL] [Abstract][Full Text] [Related]
6. [Transfusion related graft versus host disease. Indications for irradiated blood components].
Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
[No Abstract] [Full Text] [Related]
7. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion.
Higgins MJ; Blackall DP
Curr Hematol Rep; 2005 Nov; 4(6):470-6. PubMed ID: 16232385
[TBL] [Abstract][Full Text] [Related]
8. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
[TBL] [Abstract][Full Text] [Related]
9. Current risks in blood transfusion in Japan.
Otsubo H; Yamaguchi K
Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
[TBL] [Abstract][Full Text] [Related]
10. Risks associated with transfusion of cellular blood components in Canada.
Kleinman S; Chan P; Robillard P
Transfus Med Rev; 2003 Apr; 17(2):120-62. PubMed ID: 12733105
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
Klapper EB; Goldfinger D
Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
[TBL] [Abstract][Full Text] [Related]
12. Transfusion of blood components to infants under four months: review and guidelines.
O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
[No Abstract] [Full Text] [Related]
13. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
14. [Immunological aspects of blood transfusion preparations].
Matinlauri I
Duodecim; 2004; 120(7):867-75. PubMed ID: 15154308
[No Abstract] [Full Text] [Related]
15. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
[No Abstract] [Full Text] [Related]
16. Immune complications associated with chronic transfusion.
Harris DJ
J Infus Nurs; 2002; 25(5):316-9. PubMed ID: 12355057
[TBL] [Abstract][Full Text] [Related]
17. Noninfectious transfusion-associated adverse events and their mitigation strategies.
Goel R; Tobian AAR; Shaz BH
Blood; 2019 Apr; 133(17):1831-1839. PubMed ID: 30808635
[TBL] [Abstract][Full Text] [Related]
18. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
[TBL] [Abstract][Full Text] [Related]
19. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
Ann Hematol; 2004 Jan; 83(1):44-9. PubMed ID: 14551741
[TBL] [Abstract][Full Text] [Related]
20. The risks associated with blood and blood product transfusion.
Higgins C
Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
